MajesticPug
FULL MEMBER
- Joined
- Jan 29, 2021
- Messages
- 969
- Reaction score
- -12
- Country
- Location
One reason is because Moderna is a small 12 year old company that doesn't have much worldwide capacity experience while BioNTech has leveraged Pfizer (which has been around for 175 years) to help make their supply.
It's politics. US government controls the Moderna and has used this to gain geopolitically. BioNTech's vaccine IP is mainly held by BioNTech and Germany realizes this is a life-saving vaccine, not a geopolitical tool like what the White House twists it to be.
Last edited: